Aspirus Health Recognized With Inaugural 2023 Supply Chains Distinction Award

Thursday, April 4th, 2024 -- 8:01 AM

Aspirus Health has been recognized by healthcare supply chain leader Global Healthcare Exchange (GHX) as a recipient of the inaugural 2023 Supply Chains of Distinction Award.

The Supply Chains of Distinction Award honors the top performing hospitals and health systems in North America that excelled in driving best-in-class supply chain operations in 2023.

“Aspirus is gratified to receive this recognition from one of the most respected and innovative names in this industry,” says Aspirus Health Vice President & Chief Supply Chain Officer Stephen Spencer. "GHX has been an excellent partner, providing the roadmap and capabilities needed to modernize and optimize our supply chain.”

The award is based upon a set of “perfect order” metrics, rated as a percentage of PO lines sent across the GHX Exchange (integrated) that are touchless and completely automated, from purchase through payment.

“I am incredibly proud of my team for embracing the opportunities that technology has unlocked and doing the hard work to deliver the efficiencies and service level that care providers across our organization deserve and depend on,” says Spencer. “This distinction shows that Aspirus is a leader in more than just providing quality health care.”

“The Supply Chains of Distinction Award honors organizations that are redefining supply chain excellence and setting the standard for healthcare supply chains of the future,” said Tina Vatanka Murphy, president and CEO, GHX. “By embracing digital and data transformation, organizations like Aspirus are contributing directly to the sustainability of health care, making a lasting impact on the patients and families that we serve together.”

This year’s recipients will be honored at the 2024 GHX Summit taking place May 13-16, 2024 in Austin, TX. The full list of 2023 winners can be found here: https://www.ghx.com/awards/supply-chains-of-distinction/

Feel free to contact us with questions and/or comments.